• Home
  • ORGANOPlus Co., Ltd.

ORGANOPlus Co., Ltd.

About ORGANOPlus Co., Ltd.

AI Platform for Novel Strain Discovery and Functional Evaluation using Organ-on-a-Chip Technology. Microbiome-based drug (LBP) development, therapeutics/antibiotics, health functional foods, and cosmetic ingredient development

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2026
  • Employees:
    1 - 24
Company types
Other
Contact info
Show contact info Hide contact info
Meet us at

CPHI South East Asia 2026

QSNCC, Bangkok, Thailand
08 Jul 2026 - 10 Jul 2026
View Exhibitor Profile

Products from ORGANOPlus Co., Ltd. (2)

  • CANORGAN

    Product CANORGAN

    This is a human-validation oncology and immuno-oncology platform that precisely recapitulates the actual tumor microenvironment (TME) utilizing patient-derived tumor tissues, patient-derived organoids (PDOs), immune cells, and the extracellular matrix (ECM). Through a multi-channel system, various immune c...
  • VILLIORGAN

    Product VILLIORGAN

    This is a Gut-on-a-chip validation platform that biomimetically recapitulates the human intestinal villi, mucin layer, barrier function, and gut microbiota environment. Utilizing a 3D villi-shaped membrane structure, it establishes a co-culture environment with anaerobic microbes.